Effects of chronic smoking on the meibomian glands
To evaluate the effects of chronic smoking on tear function tests and meibomian glands.
This prospective study included 40 volunteers with a long-term (> 5 years) cigarette smoking history (study group) and 43 non-smoking healthy individuals (control group). The symptoms of all the participants were scored using the Ocular Surface Disease Index (OSDI) questionnaire, and a detailed ophthalmological examination was performed including the tear breakup time (TBUT) and Schirmer test (with anaesthesia). The upper and lower lid meibomian glands were evaluated with meibography using the Sirius anterior segment analysis system (Sirius, CSO, Florence, Italy).
The groups showed homogenous distribution in respect of age and gender (p > 0.05). The patients in the study group were determined with 22.59 ± 17.25 packet/year cigarette usage. The mean OSDI score was 36.67 ± 21.47 in the study group and 31.65 ± 15.60 in the control group (p = 0.64). The TBUT and Schirmer test values were determined as 9.65 ± 6.14 s and 8.90 ± 4.95 mm, respectively, in the study group and 11.23 ± 5.94 s and 13.08 ± 8.61 mm in the control group (p > 0.05). In the upper lid meibography, loss of 24.68 ± 16.54% was determined in the study group and 17.87 ± 7.06% in the control group (p = 0.01). No statistically significant difference was determined between the groups in respect of the lower lid meibomian gland loss: study group 14.70 ± 8.49% versus control group 12.48 ± 6.44% (p = 0.20).
Smoking results in meibomian gland damage which may be a risk factor for dry eye. In cases of ocular surface disorders related to chronic smoking, meibomian gland damage should be taken into consideration.
KeywordsSmoking Tear function tests Meibography
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Approval for the study was granted by the Local Ethics Committee, and all procedures were applied in conformity with the principles of the Helsinki declaration.
Informed consent was obtained from all the participants.
- 2.WHO (2010) Why tobacco is a public health priority. http://www.who.int/tobacco/health_priority/en/. Accessed 20 Aug 2010
- 3.Chiba M, Masironi R (1992) Toxic and trace elements in tobacco and tobacco smoke. Bull World Health Organ 70(2):270–276Google Scholar
- 4.Hara K (1991) Effects of cigarette smoking on ocular circulation chronic effect on choroidal circulation. Nippon Ganka Gakkai Zasshi 95(10):939–943Google Scholar
- 8.DeBlack SS (2003) Cigarette smoking as a risk factor for cataract and age-related macular degeneration: a review of the literature. Optometry 74(2):99–110Google Scholar
- 9.Lu ZQ, Sun WH, Yan J, Jiang TX, Zhai SN, Li Y (2012) Cigarette smoking, body mass index associated with the risks of age-related cataract in male patients in northeast China. Int J Ophthalmol 5(3):317–322Google Scholar
- 17.Green-Church KB, Butovich I, Willcox M, Borchman D, Paulsen F, Barabino S, Glasgow BJ (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci 52(4):1979–1993CrossRefGoogle Scholar